Development and initial validation of a self-assessed lupus organ damage instrument

Arthritis Care and Research

Volumn 62, Issue 4, 2010, Pages 559-568

  Costenbader, Karen H ^a   Khamashta, Munther ^b   Ruiz Garcia, Silvia ^b   Perez Rodriguez, Maria Teresa ^b,c   Petri, Michelle ^d   Elliott, Jennifer ^e   Manzi, Susan ^e   Karlson, Elizabeth W ^k   Turner Stokes, Tabitha ^f   Bermas, Bonnie ^a   Coblyn, Jonathan ^a   Massarotti, Elena ^a   Schur, Peter ^a   Fraser, Patricia ^a   Navarro, Iris ^g   Hanly, John G ^h   Shaver, Timothy S ⁱ   Katz, Robert S ^j   Chakravarty, Eliza ^k   Fortin, Paul R ^l   Sanchez, Martha L ^g   Liu, Jigna ^g   Michaud, Kaleb ^m   Alarcón, Graciela S ^g   Wolfe, Frederick ⁿ   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c HOSPITAL XERAL CÍES   (Spain)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ Arthritis and Rheumatology Clinics of Kansas   (United States)

^j RUSH UNIVERSITY   (United States)

^k STANFORD UNIVERSITY   (United States)

^l TORONTO WESTERN HOSPITAL   (Canada)

^m UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁿ NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALOPECIA; ARTHRITIS; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COMORBIDITY; DISABILITY; DYSPNEA; FEMALE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; OUTCOME ASSESSMENT; PHYSICIAN; PREVALENCE; RATING SCALE; SCORING SYSTEM; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; SHORT FORM 36; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDATION PROCESS;

ADULT; AGED; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 77950414914     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20193     Document Type: Article

References (43)

1. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus: patient characteristics associated with poorer outcomes. Arthritis Rheum 1995;38:274-283
2. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408-415 (Pubitemid 27084212)
3. Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:2044-2050
4. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308. (Pubitemid 37229465)
5. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M. Systemic Lupus International Collaborative Clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol 1992;19:1820-1821
6. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-369 (Pubitemid 26085211)
7. Gladman D, Goldsmith C, Urowitz M, Bacon P, Fortin P, Ginzler E, et al. The SLICC/ACR Damage Index for SLE international comparison [abstract]. Arthritis Rheum 1995;38 Suppl:S174.
8. Gladman DD, Urowitz MB. The SLICC/ACR Damage Index: progress report and experience in the field. Lupus 1999;8: 632-637
9. Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982;25:601-611
10. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-813 (Pubitemid 27199995)
11. Thumboo J, Lee HY, Fong KY, Chan SP, Chapman CA, Leong KH, et al. Accuracy of medical record scoring of the SLICC/ ACR Damage Index for systemic lupus erythematosus. Lupus 2000;9:358-362 (Pubitemid 30389038)
12. Nossent JC. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. J Rheumatol 1998;25:654-659
13. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ ACR) Damage Index for systemic lupus erythematosus international comparison. J Rheumatol 2000;27:373-376 (Pubitemid 30095466)
14. Vila LM, Alarcon GS, McGwin G Jr, Friedman AW, Baethge BA, Bastian HM, et al. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford) 2004;43:358-363
15. Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR Damage Index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001;10:93-96 (Pubitemid 32410092)
16. Nived O, Jonsen A, Bengtsson AA, Bengtsson C, Sturfelt G. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for survival in systemic lupus erythematosus. J Rheumatol 2002;29:1398-1400 (Pubitemid 34755603)
17. Mok CC, Ho LY, Cheung MY, Yu KL, To CH. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scand J Rheumatol 2009;38:121-127
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25: 1271-1277
19. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
20. Wolfe F, Michaud K. A brief introduction to the National Data Bank for Rheumatic Diseases. Clin Exp Rheumatol 2005;23: S168-71. (Pubitemid 46657524)
21. Wolfe F, Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 2008;58:2612-2621
22. Sanchez ML, Costenbader KH, Karlson EW, Alarcon GS, Wolfe F. Is it possible to ascertain damage in lupus utilizing a self-reported questionnaire? Preliminary data on the Lupus Damage Index Questionnaire (LDIQ) [abstract]. Arthritis Rheum 2007;56 Suppl:S777.
23. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483
24. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form health survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
25. Warley AR, Finnegan OC, Nicholson EM, Laszlo G. Grading of dyspnoea and walking speed in cardiac disease and in chronic airflow obstruction. Br J Dis Chest 1987;81:349-355
26. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-145
27. Liang MH, Fortin PR, Isenberg DA, Snaith L. Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agenda. Rheumatol Int 1991;11:133-136
28. Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003;12:280-286
29. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the Systemic Lupus Erythematosus Activity Questionnaire in a large observational cohort. Arthritis Rheum 2008;59:136-143
30. Michaud K, Wolfe F. The development of a rheumatic disease research comorbidity index for use in outpatients patients with RA, OA, SLE and fibromyalgia (FMS) [abstract]. Arthritis Rheum 2007;56 Suppl:S596.
31. Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:885-906.
32. Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 1999;58:379-381
33. Hanly JG. Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study. Lupus 1997;6:243-247
34. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998;17:478-484
35. Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998;7:101-107
36. Alarcon GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. Arthritis Rheum 2001;45:191-202.
37. Stoll T, Seifert B, Isenberg DA. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996;35:248-254
38. Zonana-Nacach A, Camargo-Coronel A, Yanez P, de Lourdes S, Jimenez-Balderas FJ, Aceves-Avila J, et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998;7:119-123
39. Alarcon GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001;44:2797-2806
40. Bertoli AM, Alarcon GS, Calvo-Alen J, Fernandez M, Vila LM, Reveille JD, for the LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort: clinical features, course, and outcome in patients with late-onset disease. Arthritis Rheum 2006;54:1580-1587
41. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001;28:525-532
42. Brunner HI, Feldman BM, Urowitz MB, Gladman DD. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement. J Rheumatol 2003;30:292-297
43. Pons-Estel BA, Sanchez-Guerrero J, Romero-Diaz J, Iglesias-Gamarra A, Bonfa E, Borba EF, et al. Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index Questionnaire: data from North and South America, Spain and Portugal. Lupus 2009;18:1033-1052